Search results for "Regulatory Review"
It's a numbers game: How should physicians inform patients about risk?
A recent Annals of Internal Medicine article on risk communication highlighted the critical role of the physician in influencing patients' treatment decisions.
https://immattersacp.org/archives/2008/02/editor.htm
1 Feb 2008
Montelukast examined for link to suicidal thoughts, actions
Warnings, recalls, label changes, and approvals.
https://immattersacp.org/archives/2008/05/eighteen.htm
1 May 2008
Fentanyl pain-relief patches recalled for packaging defect
Warnings, recalls, label changes, and approvals.
https://immattersacp.org/archives/2008/04/twentytwo.htm
1 Apr 2008
AI_Jan08_FINAL
REGULATORY REVIEW. Alerts, warnings and recalls. The boxed warningfor rosiglitazone(Avandia) was re-vised to reflect a potentialincreased risk of heart attacks. ... Antifibrinolytic drug aprotinin injec-tion (Trasylol) was temporarily pulledfrom the market pending review of study.
https://immattersacp.org/archives/2008/01/acpi-200801-campaign_t1.pdf
20 Dec 2007
Letters
Readers respond to Mindful Medicine, Ethics columns.
https://immattersacp.org/archives/2008/02/letters.htm
1 Feb 2008